Skip to Content
Search Menu

Borderline Ovarian Tumors Increase Risk of Some Non-Ovarian Cancers

A large Danish nationwide study of almost 5000 women with borderline ovarian tumors (BOT) has found increased risks of several non-ovarian cancers.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

Marco Donia

Adjuvant Immunotherapy of Melanoma: The Current Status and Outlook for the Next Few Years

/ Marco Donia
Melanoma Play the Video 06:00
Miriam Grønberg

Treatment Timing Impacts Survival in Limited Stage Small Cell Lung Cancer

/ Miriam Grønberg
Lung cancer Play the Video 07:04

Continued Progress for the Treatment of Gynecological Cancer But No Game-Changer

/ BestPractice Nordic
ESMO24Gynecological cancer

New Treatment Possibilities Improve Future Outcomes of Lung Cancer

/ BestPractice Nordic
ESMO24Lung cancer

The Choice of Immunotherapy and PARP Inhibitor for Gynecological Cancer

/ BestPractice Nordic
ESMO24Gynecological cancer

Ten-Year Survival Data from a Groundbreaking Trial for the Treatment of Metastatic Melanoma

/ BestPractice Nordic
ESMO24Melanoma

No Major Breakthroughs in Lung Cancer Compared to ESMO 2023

/ BestPractice Nordic
ESMO24Lung cancer

The Ultimate Proof That Immunotherapy Can Be Curative for Metastatic Malignant Melanoma

/ BestPractice Nordic
ESMO24Melanoma
Mansoor Raza Mirza

ESMO 2024: Hope and Disappointment for Ovarian Cancer Treatment

/ Mansoor Raza Mirza
ESMO24Gynecological cancer Play the Video 09:55
Back to top